Veterans Aging Cohort Study-Charlson Comorbidity Index (VACS-CCI)
Estimates risk of all-cause mortality in patients with comorbidities, including non-metastatic prostate cancer.
This tool assists in calculating all cause mortality in the general population and in patients with non-metastatic prostate cancer.
Advice
VACS-CCI may be used at the bedside to assist in discussions regarding mortality and chronic disease.